Objectives: This study sought to evaluate the use of a continuous-flow rotary left ventricular
assist device (LVAD) as a bridge to heart transplantation. Background: LVAD therapy is an …

BACKGROUND: A multicenter clinical trial conducted from 2005 to 2008 of a continuous
flow left ventricular assist device (LVAD) resulted in Food and Drug Administration approval …

OBJECTIVE: Although left ventricular assist devices (LVADs) are associated with excellent
outcomes in patients with end-stage heart failure, there are conflicting reports on …

PURPOSE: Newer continuous-flow left ventricular assist devices (LVAD) have the
advantage of smaller size and increased durability. Questions remain regarding the safety …

Continuous-flow left ventricular assist devices (LVAD) have emerged as the standard of care
for advanced heart failure patients requiring long-term mechanical circulatory support …

BACKGROUND: Limited data exist about the long-term effects of continuous-flow vs
pulsatile-flow left ventricular assist devices (LVADs) on end-organ function. METHODS: We …

Objectives: This study sought to assess the impact of continuous flow left ventricular assist
devices (LVADs) on functional capacity and heart failure-related quality of life. Background …

BACKGROUND: Continuous-flow (CF) pumps have yielded improvements in short-and long-
term survival and quality of life, and have reduced the number of left ventricular assist device …

The use of left ventricular assist devices (LVADs) has increased significantly over the past
few years, in part because heart transplant activity has plateaued, but also because of the …

Congestive heart failure (HF) remains a serious burden in the Western World. Despite
advances in pharmacotherapy and resynchronization, many patients have progression to …